摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2,4-Trimethyl-1,2-dihydroquinolin-6-yl benzoate | 5493-40-3

中文名称
——
中文别名
——
英文名称
2,2,4-Trimethyl-1,2-dihydroquinolin-6-yl benzoate
英文别名
(2,2,4-trimethyl-1H-quinolin-6-yl) benzoate
2,2,4-Trimethyl-1,2-dihydroquinolin-6-yl benzoate化学式
CAS
5493-40-3
化学式
C19H19NO2
mdl
MFCD00809935
分子量
293.4
InChiKey
OEEHFISDBQJLJD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • COMPOSITIONS AND METHODS RELATING TO HIV PROTEASE INHIBITION
    申请人:Carlson Heather A.
    公开号:US20110105477A1
    公开(公告)日:2011-05-05
    The present invention relates to HIV protease, and methods for inhibiting the function of HIV protease. In particular, present invention provides compounds that inhibit or block the biological activity of HIVp, thereby causing the replication of the HIV virus to be inhibited or to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS. The compounds and formulations also find use in diagnostic and research settings.
  • [EN] COMPOSITIONS AND METHODS RELATING TO HIV PROTEASE INHIBITION<br/>[FR] COMPOSITIONS ET PROCÉDÉS LIÉS À L'INHIBITION DE LA VIH PROTÉASE
    申请人:UNIV MICHIGAN
    公开号:WO2009036341A2
    公开(公告)日:2009-03-19
    The present invention relates to HIV protease, and methods for inhibiting the function of HIV protease. In particular, present invention provides compounds that inhibit or block the biological activity of HIVp, thereby causing the replication of the HIV virus to be inhibited or to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS. The compounds and formulations also find use in diagnostic and research settings.
查看更多